Lung Science Conference
Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
TP226 - The Cathelicidin LL-37 and microbial dysbiosis in COPD patients receiving inhaled corticosteroids
Holly Rachael Keir, United Kingdom
ERS Lung Science Conference 2022
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Holly Rachael Keir, United Kingdom. TP226 - The Cathelicidin LL-37 and microbial dysbiosis in COPD patients receiving inhaled corticosteroids. ERS Lung Science Conference 2022
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Definition and history of sarcoidosis
How smoking modifies inflammation and immunology of asthma
LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD